检索结果 - Irene Virgolini

Refine Results
  1. 1
    Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: Agonist, Antagonist and Alternatives

    Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: Agonist, Antagonist and Alternatives 由 Giulia Santo, Gianpaolo di Santo, Irene Virgolini

    出版 2024
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy

    Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy 由 Michael Gabriel, Bernhard Nilica, Bernhard Kaiser, Irene Virgolini

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023

    Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023 由 Gianpaolo di Santo, Giulia Santo, Anna Sviridenko, Irene Virgolini

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors

    Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors 由 Giulia Santo, Gianpaolo di Santo, Francesco Cicone, Irene Virgolini

    出版 2025
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Current status of theranostics in prostate cancer

    Current status of theranostics in prostate cancer 由 Irene Virgolini, Clemens Decristoforo, Alexander Haug, Stefano Fanti, Christian Uprimny

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study

    Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study 由 Klaus Kapelari, Christine Kirchlechner, Wolfgang Högler, Katharina Schweitzer, Irene Virgolini, Roy Moncayo

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    [68Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis

    [68Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis 由 Roland Haubner, Armin Finkenstedt, Armin Stegmayr, Christine Rangger, Clemens Decristoforo, Heinz Zoller, Irene Virgolini

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Left hemispheric predominance of nigrostriatal dysfunction in Parkinson’s disease

    Left hemispheric predominance of nigrostriatal dysfunction in Parkinson’s disease 由 Christoph Scherfler, Klaus Seppi, Katherina Mair, Eveline Donnemiller, Irene Virgolini, Gregor K. Wenning, Werner Poewe

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review

    Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review 由 Finn Edler von Eyben, Giandomenico Roviello, Timo Kiljunen, Christian Uprimny, Irene Virgolini, Kalevi Kairemo, Timo Joensuu

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    Response of Recurrent High-Grade Glioma to Treatment with <sup>90</sup>Y-DOTATOC

    Response of Recurrent High-Grade Glioma to Treatment with <sup>90</sup>Y-DOTATOC 由 Dirk Heute, H. Kostron, Elisabeth von Guggenberg, Shota Ingorokva, Michael Gabriel, Georg Dobrozemsky, Günther Stockhammer, Irene Virgolini

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer

    Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer 由 Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klinger, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt, Gianpaolo di Santo, Irene Virgolini

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use

    DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use 由 Maximilian Klingler, Dominik Summer, Christine Rangger, Roland Haubner, Julie Foster, Jane Sosabowski, Clemens Decristoforo, Irene Virgolini, Elisabeth von Guggenberg

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Bone Metastases in Patients with Neuroendocrine Tumor: <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET in Comparison to CT and Bone Scintigraphy

    Bone Metastases in Patients with Neuroendocrine Tumor: <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET in Comparison to CT and Bone Scintigraphy 由 Daniel Putzer, Michael Gabriel, Benjamin Henninger, Dorota Kendler, Christian Uprimny, Georg Dobrozemsky, Clemens Decristoforo, Reto Bale, Werner Jaschke, Irene Virgolini

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy

    <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy 由 Michael Gabriel, Andreas Oberauer, Georg Dobrozemsky, Clemens Decristoforo, Daniel Putzer, Dorota Kendler, Christian Uprimny, Péter Kovács, Reto Bale, Irene Virgolini

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

    68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT 由 Michael Gabriel, Clemens Decristoforo, Dorota Kendler, Georg Dobrozemsky, Dirk Heute, Christian Uprimny, Péter Kovács, Elisabeth von Guggenberg, Reto Bale, Irene Virgolini

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme

    Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme 由 Eva‐Maria Gamper, Lisa M. Wintner, Margarida Rodrigues, Sabine Buxbaum, Bernhard Nilica, Susanne Singer, Johannes M. Giesinger, Bernhard Holzner, Irene Virgolini

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification

    Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification 由 Alexander Kroiss, Daniel Putzer, Christian Uprimny, Clemens Decristoforo, Michael Gabriel, Wolfram Santner, Christof Kranewitter, Boris Warwitz, Dietmar Waitz, Dorota Kendler, Irene Virgolini

    出版 2012
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  18. 18
    Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle

    Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycl... 由 Bernhard Nilica, Dietmar Waitz, Vlado Stevanovic, Christian Uprimny, Dorota Kendler, Sabine Buxbaum, Boris Warwitz, Llanos Gerardo, Benjamin Henninger, Irene Virgolini, Margarida Rodrigues

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates

    The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates 由 Lorenza Scarpa, Sabine Buxbaum, Dorota Kendler, Katharina Fink, Jasmin Bektić, Leonhard Gruber, Clemens Decristoforo, Christian Uprimny, Peter Lukáš, Wolfgang Horninger, Irene Virgolini

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Vasoactive Intestinal Peptide-Receptor Imaging for the Localization of Intestinal Adenocarcinomas and Endocrine Tumors

    Vasoactive Intestinal Peptide-Receptor Imaging for the Localization of Intestinal Adenocarcinomas and Endocrine Tumors 由 Irene Virgolini, Markus Raderer, Amir Kurtaran, P. Angelberger, S. Banyai, Qiong Yang, Shuren Li, Martin Banyai, Johann Pidlich, Bruno Niederle, Werner Scheithauer, Peter Valent

    出版 1994
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: